tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Shanghai Henlius Biotech Secures EU GMP Certification for Key Biosimilars
PremiumCompany AnnouncementsShanghai Henlius Biotech Secures EU GMP Certification for Key Biosimilars
1M ago
Shanghai Henlius Secures Exclusive Rights for HCB101 Development
Premium
Company Announcements
Shanghai Henlius Secures Exclusive Rights for HCB101 Development
1M ago
Shanghai Henlius Biotech Proposes New Share Option and RSU Schemes
Premium
Company Announcements
Shanghai Henlius Biotech Proposes New Share Option and RSU Schemes
1M ago
Shanghai Henlius Initiates Japanese Study for Cancer Treatment
PremiumCompany AnnouncementsShanghai Henlius Initiates Japanese Study for Cancer Treatment
1M ago
Shanghai Henlius Biotech Initiates Phase 2 Study of HLX43 for Lung Cancer
Premium
Company Announcements
Shanghai Henlius Biotech Initiates Phase 2 Study of HLX43 for Lung Cancer
2M ago
Shanghai Henlius Biotech Gains Approval for H Share Full Circulation
Premium
Company Announcements
Shanghai Henlius Biotech Gains Approval for H Share Full Circulation
2M ago
Shanghai Henlius Partners with Sandoz for Global Commercialization of HLX13
PremiumCompany AnnouncementsShanghai Henlius Partners with Sandoz for Global Commercialization of HLX13
3M ago
Shanghai Henlius Biotech Advances Phase 3 Trial for Cancer Treatment
Premium
Company Announcements
Shanghai Henlius Biotech Advances Phase 3 Trial for Cancer Treatment
3M ago
Shanghai Henlius Biotech Partners with Alvogen Korea for Cancer Drug Commercialization
Premium
Company Announcements
Shanghai Henlius Biotech Partners with Alvogen Korea for Cancer Drug Commercialization
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100